Variation of bone marrow CD34+ cell subsets in myelodysplastic syndromes according to who types

Neoplasma

Volumn 56, Issue 5, 2009, Pages 435-440

  Reis, S C ^a   Traina, F ^a   Metze, K ^a   Saad, S T O ^a   Lorand Metze, I ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Blasts; Hematogones; Myelodysplasia; SSC; WHO type

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL POPULATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYELOBLAST; MYELODYSPLASTIC SYNDROME; PRE B LYMPHOCYTE; PROGNOSIS; QUANTITATIVE ANALYSIS; WORLD HEALTH ORGANIZATION; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD13; ANTIGENS, CD34; BONE MARROW CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 69849109645     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_05_435     Document Type: Article

References (15)

1. Lorand-Metze I, Ribeiro E, Lima CSP et al. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res 2007; 31: 147-155 doi:10.1016/j.leukres.2006.04.010 PMid:16750852 (Pubitemid 44854190)
2. Wells DA, Benesch M, Loken MR et al. Myeloid and monocytic dispoiesis as determinated by flow cytometry scoring in myelodysplastic syndromes correlates with the IPSS and with outcome after hemopoietic stem cell transplantation. Blood 2003; 102: 394-405. doi:10.1182/blood-2002-09-2768 PMid:12649150 (Pubitemid 36759682)
3. Ogata K, Kishikawa Y, Satoh C et al. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 2006; 108: 1037-1044. doi:10.1182/blood-2005-12-4916 PMid:16574954 (Pubitemid 44154642)
4. Satoh C, Dan K, Yamashita T et al. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes. Leuk Res. 2008; 32: 699-707. doi:10.1016/j.leukres.2007.08.022 PMid:17936901 (Pubitemid 351323926)
5. Lorand-Metze I, Califani SMV, Ribeiro E, Lima CSP et al. The impact of phenotypic abnormalities on survival of myelodysplastic syndromes. Leuk Res 2007; 31 (suppl 1): S131. doi:10.1016/S0145-2126(07)70236-9
6. Pirrucello SJ, Young KH, Aoun P. Myeloblast phenotypic changes in myelodysplasia. Am J Clin Pathol 2006; 125: 884-894 doi:10.1309/J3ET7RXD1X4BKDLF PMid:16690488
7. Lorand-Metze I, Califani SMV, Ribeiro E et al. The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes. Leuk Res 2008; 32: 211-213. doi:10.1016/j.leukres.2007.06.014 PMid:17675154 (Pubitemid 351215545)
8. Zelezniková T, Stevulova L, Kovarikova A et al. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Neoplasma 2007; 54: 471-477.
9. Pereira FG, Metze K, Costa FPS et al. Phenotypic quantitative features of patients with acute myeloid leukemia. Neoplasma 2006; 53: 155-160
10. Zelezniková T, Babusiková O. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry. Neoplasma 2005; 52: 517-522. (Pubitemid 41809412)
11. Ribeiro E, Matarraz Sudón S, Santiago M et al. Maturationassociated immnophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes. Leuk Res 2006; 30: 9-16. doi:10.1016/j.leukres. 2005.05.019 PMid:16005514 (Pubitemid 41654698)
12. Maftoun-Banankhah S, Maleki A, Karandikar NJ et al. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes. Am J Clin Pathol 2008; 129: 300-308. doi:10.1309/4W2G3NDXUPG5J33N PMid:18208811 (Pubitemid 352029321)
13. Matarraz S, Lopez A, Barrena S et al. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 2008; 22:1175-1183. doi:10.1038/leu.2008.49 PMid:18337765 (Pubitemid 351833785)
14. Vardiman JW, Harris NL, Brunning R. The World Heath Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-2302. doi:10.1182/blood-2002-04-1199 PMid:12239137
15. Loken MR, van de Loosdrecht A, Ogata K et al. Flow cytometry in myelodysplastic syndromes: report from a consensus working conference. Leukemia Res 2008; 32: 5-17. doi:10.1016/j.leukres.2007.04.020 PMid:17576013 (Pubitemid 350100844)